Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of 47.53 million. The enterprise value is -13.40 million.
| Market Cap | 47.53M |
| Enterprise Value | -13.40M |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
| Current Share Class | 979.95M |
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 0.64% |
| Float | 953.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.73 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.13 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.52 |
Financial Position
The company has a current ratio of 9.89, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.89 |
| Quick Ratio | 8.88 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.79% and return on invested capital (ROIC) is -11.28%.
| Return on Equity (ROE) | -55.79% |
| Return on Assets (ROA) | -10.78% |
| Return on Invested Capital (ROIC) | -11.28% |
| Return on Capital Employed (ROCE) | -24.60% |
| Revenue Per Employee | 181,072 |
| Profits Per Employee | -668,625 |
| Employee Count | 152 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.04% in the last 52 weeks. The beta is 1.63, so Zomedica's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -71.04% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 55.16 |
| Average Volume (20 Days) | 1,326,240 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zomedica had revenue of 27.52 million and -101.63 million in losses. Loss per share was -0.11.
| Revenue | 27.52M |
| Gross Profit | 19.38M |
| Operating Income | -33.36M |
| Pretax Income | -102.08M |
| Net Income | -101.63M |
| EBITDA | -25.09M |
| EBIT | -33.36M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 63.61 million in cash and 2.68 million in debt, giving a net cash position of 60.93 million or 0.06 per share.
| Cash & Cash Equivalents | 63.61M |
| Total Debt | 2.68M |
| Net Cash | 60.93M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 132.44M |
| Book Value Per Share | 0.14 |
| Working Capital | 65.82M |
Cash Flow
In the last 12 months, operating cash flow was -22.69 million and capital expenditures -3.16 million, giving a free cash flow of -25.85 million.
| Operating Cash Flow | -22.69M |
| Capital Expenditures | -3.16M |
| Free Cash Flow | -25.85M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | 70.40% |
| Operating Margin | -121.20% |
| Pretax Margin | -370.89% |
| Profit Margin | n/a |
| EBITDA Margin | -91.16% |
| EBIT Margin | -121.20% |
| FCF Margin | n/a |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -213.84% |
| FCF Yield | -54.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |